Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6588
|
pubmed:dateCreated |
1996-11-13
|
pubmed:abstractText |
Very little is known about the receptors and target molecules involved in natural killer (NK) cell activity. Here we present a model system in which interleukin-2-activated killing by NK cells depends on the intercellular adhesion molecule ICAM-2 and is regulated by the distribution of ICAM-2. The level of ICAM-2 expression in NK-sensitive and resistant cells is similar, but in sensitive cells ICAM-2 is concentrated into bud-like cellular projections known as uropods, whereas in resistant cells it is evenly distributed. The cytoskeletal-membrane linker protein ezrin is also localized in uropods. Transfection of human ezrin into NK-resistant cells induces uropods formation, redistribution of ICAM-2 and ezrin, and sensitizes target cells to interleukin-2-activated killing. These results reveal a new mechanism of target-cell recognition: cytotoxic cells recognize adhesion molecules that are already present on normal cells, but in diseased cells are concentrated into a biologically active cell-surface region by cytoskeletal reorganization. The results also highlight the importance of cytoskeletal interactions in the regulation of ICAM-2-mediated adhesive phenomena.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Cytoskeletal Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ICAM2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/ezrin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
382
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
265-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8717043-Animals,
pubmed-meshheading:8717043-Antigens, CD,
pubmed-meshheading:8717043-Cell Adhesion Molecules,
pubmed-meshheading:8717043-Cell Line,
pubmed-meshheading:8717043-Chromosomes, Human, Pair 6,
pubmed-meshheading:8717043-Cytoskeletal Proteins,
pubmed-meshheading:8717043-Cytotoxicity, Immunologic,
pubmed-meshheading:8717043-Humans,
pubmed-meshheading:8717043-Hybrid Cells,
pubmed-meshheading:8717043-Interleukin-2,
pubmed-meshheading:8717043-Killer Cells, Natural,
pubmed-meshheading:8717043-Lymphocyte Activation,
pubmed-meshheading:8717043-Mice,
pubmed-meshheading:8717043-Phosphoproteins,
pubmed-meshheading:8717043-Transfection,
pubmed-meshheading:8717043-Tumor Cells, Cultured
|
pubmed:year |
1996
|
pubmed:articleTitle |
ICAM-2 redistributed by ezrin as a target for killer cells.
|
pubmed:affiliation |
Department of Pathology, University of Helsinki, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|